Literature DB >> 18472931

Inhaled Nitric Oxide Counterbalances ET-1 Dependent Pulmonary Hypertension and Bronchoconstriction in the Pig.

M G Clement1, M Dimori.   

Abstract

In anaesthetized, paralysed, ventilated pigs the ability of inhaled nitric oxide (80 ppm in 0(2)) to reduce the haemodynamic and respiratory effects of endothelin-1 administration (200 pmol/kg, i.v.) was evaluated. The mechanical properties of the respiratory system were evaluated by the rapid airway occlusion technique. The overall respiratory resistance, the interrupter resistance and the additional resistance that reflects the viscoelastic properties of tissues and the inequality of the time constant within the system were also evaluated. The results show that inhaled nitric oxide can act as a selective pulmonary vasodilator and as a bronchodilator to counteract the vasoconstrictor and bronchoconstrictor activity of endothelin-1. In the pig, nitric oxide inhaled at 80 ppm for 6 mitt reduced the changes in respiratory-, interrupter- and additional resistance due to endothelin-1 administration without significantly changing the static and dynamic elastance of the respiratory system.

Entities:  

Year:  1994        PMID: 18472931      PMCID: PMC2367028          DOI: 10.1155/S0962935194000165

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  26 in total

1.  Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin.

Authors:  A Wennmalm; G Benthin; A S Petersson
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

2.  Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

Authors:  C Frostell; M D Fratacci; J C Wain; R Jones; W M Zapol
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

3.  Bronchodilator action of inhaled nitric oxide in guinea pigs.

Authors:  P M Dupuy; S A Shore; J M Drazen; C Frostell; W A Hill; W M Zapol
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 4.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

5.  Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.

Authors:  J Pepke-Zaba; T W Higenbottam; A T Dinh-Xuan; D Stone; J Wallwork
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

6.  Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins.

Authors:  T F Lüscher; Z Yang; M Tschudi; L von Segesser; P Stulz; C Boulanger; R Siebenmann; M Turina; F R Bühler
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

7.  Endothelium-derived factors modulate contraction of bronchial smooth muscle.

Authors:  A J McLarty; C G McGregor; V M Miller
Journal:  Am J Physiol       Date:  1993-05

8.  Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans.

Authors:  M G Belvisi; C D Stretton; M Yacoub; P J Barnes
Journal:  Eur J Pharmacol       Date:  1992-01-14       Impact factor: 4.432

9.  Direct effects on airway smooth muscle contractile response caused by endothelin-1 in guinea pig trachealis.

Authors:  S R White; D P Hathaway; J G Umans; A R Leff
Journal:  Am Rev Respir Dis       Date:  1992-02

10.  Vagal control of guinea pig tracheal smooth muscle: lack of involvement of VIP or nitric oxide.

Authors:  N Watson; J Maclagan; P J Barnes
Journal:  J Appl Physiol (1985)       Date:  1993-04
View more
  2 in total

1.  Inhaled Nitric Oxide Reverses Vascular and Respiratory Effects of ET-1 and PAF in Pigs.

Authors:  M Albertini; M G Clement; M Dimori
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

2.  Inhibition of Immune Complex-Induced Inflammation by A small Molecular Weight Selectin Antagonist.

Authors:  X Nair; G Todderud; L Davern; D Lee; A Aruffo; K M Tramposch
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.